What is Solid Biosciences Inc.'s operating margin?

Solid Biosciences Inc. (SLDB) reported operating margin of -1,315.2% in Q4 2022.

How has Solid Biosciences Inc.'s operating margin changed year-over-year?

Solid Biosciences Inc.'s operating margin decreased by 147.9% year-over-year, from -530.5% to -1,315.2%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Solid Biosciences Inc. SLDB Operating margin

Discontinued — last reported Q4 '22

Operating margin at other companies

Sarepta Therapeutics, Inc.SRPT

-50.8%-1.6pp

Neurocrine BiosciencesNBIX

25.4%+4.9pp

InsmedINSM

-140.6%-43.9pp

Taysha Gene Therapies, Inc.TSHA

-1,774.4%+1,437pp

uniQureQURE

-1,059.7%+380pp

CRISPR TherapeuticsCRSP

-15,754.2%-17,253pp

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+145%

Enterprise value$634.23M+244%

P/S112.5×-10.3×

Profitability

See full

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

operating income/total revenue=-1,315.2%

Based on trailing twelve months.

The official record: Solid Biosciences Inc.’s 10-K, filed March 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s operating margin?: Solid Biosciences Inc. (SLDB) reported operating margin of -1,315.2% in Q4 2022.
How has Solid Biosciences Inc.'s operating margin changed year-over-year?: Solid Biosciences Inc.'s operating margin decreased by 147.9% year-over-year, from -530.5% to -1,315.2%.
What does operating margin mean?: Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.